Aggressive Diabetes Therapy May Raise Death Risk March 2, 2011 -- New results from a large government-run trial confirm that very aggressive treatment to lower blood sugar is associated with an increased risk of death in people with type 2 at high risk for heart attack and stroke.

The five-year follow-up from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study confirms findings that ended the trial’s aggressive blood sugar control arm due to safety concerns.

The study was designed to determine if intensive blood sugar, blood pressure, or cholesterol lowering with intensive treatment would improve outcomes and reduce deaths among people with type 2 diabetes with heart disease or multiple cardiovascular risk factors.

In February 2008, the National Heart, Lung, and Blood Institute (NHLBI) announced that the intensive blood sugar lowering arm of the study would be halted 18 months early after investigators reported an increase in deaths among patients in the aggressive treatment group.

Various diabetes drugs were used to lower blood sugar in the trial. The higher death rate in the tight control arm was not blamed on any single treatment.

Slideshow: 12 Tips to Avoid Diabetes Complications